Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis.
Purity:
>99.0%
CAS Number:
[1608108-91-3]
Target:
Amyloid
* VAT and and shipping costs not included. Errors and price changes excepted